SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059394
Filing Date
2023-11-06
Accepted
2023-11-06 16:11:19
Documents
83
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20230930.htm   iXBRL 10-Q 4453582
2 EX-31.1 fgen-ex31_1.htm EX-31.1 10126
3 EX-31.2 fgen-ex31_2.htm EX-31.2 10114
4 EX-32.1 fgen-ex32_1.htm EX-32.1 10135
  Complete submission text file 0000950170-23-059394.txt   14951310

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20230930_pre.xml EX-101.PRE 542256
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20230930.xsd EX-101.SCH 97144
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20230930_lab.xml EX-101.LAB 628975
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fgen-20230930_cal.xml EX-101.CAL 77449
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fgen-20230930_def.xml EX-101.DEF 370772
77 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20230930_htm.xml XML 2976141
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 231380082
SIC: 2834 Pharmaceutical Preparations